PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Cambridge Institute of Therapeutic Immunology and Infectious Disease, Cambridge,United Kingdom.\', \'Department of Medicine, University of Cambridge, Cambridge,United Kingdom.\', \'Department of Veterinary Medicine, Faculty of Agriculture, University of Miyazaki, Miyazaki,Japan.\', \'National Centre for Disease Control, Delhi,India.\', \'Department of Hematology and Oncology, Kyoto University, Kyoto,Japan.\', \'Division of Systems Virology, Institute of Medical Science, University of Tokyo, Tokyo, Japan.\', \'CSIR Institute of Genomics and Integrative Biology, Delhi,India.\', \'Department of Pathology, National Institute of Infectious Diseases, Tokyo,Japan.\', \'CREST , Japan Science and Technology Agency, Saitama,Japan.\', \'Africa Health Research Institute, Durban,South Africa.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/infdis/jiab368
?:hasPublicationType
?:journal
  • The Journal of infectious diseases
is ?:pmid of
?:pmid
?:pmid
  • 34260717
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
?:title
  • SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34260717>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34260717>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all